HongShan is a China-focused venture firm led by Neil Shen, operating separately from Sequoia Capital and Peak XV. Its AI investments cover foundation models, embodied intelligence, autonomous driving and computer vision, with exposure to companies including MiniMax and Unitree Robotics.
Model developers can pursue different research, distribution and deployment strategies. Compare the selected companies individually rather than assuming that a broad portfolio establishes a single winning technical approach. Historical backing should also be distinguished from a confirmed current holding.
The firm's seed vehicle entered Unitree Robotics at Pre-A in December 2019 with RMB 15M at a RMB 150M post-money valuation, then followed nearly every round to a 7.11% stake worth over RMB 2.5B on paper — the seed fund's first investment and the template for how HongShan compounds early conviction.
Rather than picking one robot winner, HongShan funded each layer of the stack: the brain (AgiBot), perception (Mech-Mind), hands (LinkerBot), feet (Lingzu Tech), force-controlled arms (Agile Robots), warehouse and consumer robots (Hai Robotics, Narwal, AgileX) and rehabilitation robotics (Fourier).
From 2020 the firm systematically backed Neuracle, NeuroXess, Zhiran Medical and SceneRay, entering a category most institutional investors only discovered around 2025 and holding it with unusually long patience.
HongShan is the China business formerly known as Sequoia Capital China. Sequoia announced a three-way split of its global partnership in June 2023 and completed it in March 2024, since when HongShan has been a legally and financially separate partnership from Sequoia Capital in the US and Peak XV Partners in India and Southeast Asia.
Disclosed HongShan AI investments across foundation models, agents and applications, embodied intelligence, autonomous driving and vision, and brain-computer interfaces.
Maker of Kimi. HongShan has backed every round since the angel financing.
Led a US$50M A+ round, then repeated follow-ons; third largest financial shareholder at 3.81% before listing.
One of the early institutional investors in the GLM model family.
One of China's multimodal model leaders; HongShan is an investor.
Co-led the Series A; Manus went viral in March 2025 with two million users queuing within a week.
HongShan holds 2.41% and is the sixth largest shareholder ahead of the company's IPO attempt.
Seed fund entered at Pre-A in December 2019 (RMB 15M at RMB 150M post-money) and added across rounds to a 7.11% stake, over RMB 2.5B on paper.
The 'brain' position in HongShan's embodied intelligence map.
The 'perception' position — AI-powered industrial 3D vision.
The 'hands' position — dexterous robotic hands.
Develops integrated robotic joint actuators.
Case-handling mobile robots for automated warehouses.
Force-sensing intelligent robot arms.
Listed company spanning personal mobility and robotic lawn mowers.
Rehabilitation and general-purpose humanoid robotics.
Premium robot floor cleaners.
Robotic arms and mobile chassis used widely in embodied AI research.
HongShan led the company's first financing and invested in four consecutive rounds.
Listed autonomous-driving compute platform.
Listed computer vision and multimodal AI group.
Entered at Series A in 2015 and added across multiple later rounds.
Backed from 2020, led internally by partner Yunxia Yang.
Early investor in this flexible high-bandwidth BCI company.
Early-stage BCI investment.
Early-stage investment in implantable neuromodulation and BCI devices.
A selected, non-exhaustive sample of the firm's wider internet and consumer track record.
Early backer of the TikTok and Douyin parent.
Long-held position in China's largest local commerce platform.
Early investor in the PDD Holdings marketplace.
Early institutional investor.
Investor in the global drone leader.
Shunwei CapitalShunwei Capital is a Beijing-based venture firm founded in 2011 by Xiaomi's Lei Jun, operating as the financial arm closest to the Xiaomi ecosystem. Its AI strategy avoids the frontier parameter race, concentrating instead on embodied intelligence and robotics, silicon and compute, and vertical AI applications. It is one of China's most concentrated backers of humanoid robotics.
Lollapalooza CapitalLollapalooza Capital is a Hong Kong-based, founder-led investment firm and family office founded in 2025 by Meituan co-founder Huiwen Wang. It combines primary market conviction with a public market perspective, backing category-defining founders across large language models, AI infrastructure, applications and embodied intelligence.
AccelApp creation, coding tools and developer infrastructure.
No — and has not been since March 2024. Sequoia announced the three-way split of its global partnership in June 2023 and completed it in March 2024: HongShan (the former Sequoia Capital China, led by Neil Shen), Sequoia Capital in the US and Europe, and Peak XV in India and Southeast Asia are legally and financially separate partnerships. Every position on this page is HongShan's alone.
Because Unitree is the template for how HongShan compounds early conviction: the seed vehicle's first investment, in December 2019, was RMB 15M at a RMB 150M post-money valuation — and it followed nearly every round to a 7.11% stake worth over RMB 2.5B on paper, implying a company value near RMB 35B, over 200 times its entry post-money. Adding on proof, not on price, is the pattern.
Compare the company, model strategy, deployment market and timing of the disclosed relationship. A selected portfolio does not establish complete coverage of a market, and an investment relationship does not by itself confirm a current holding.
Like a bill of materials: AgiBot as the brain, Mech-Mind for 3D perception, LinkerBot's dexterous hands, Lingzu's foot actuators, Agile Robots' force-controlled arms, plus warehouse and consumer bodies (Hai Robotics, Narwal, AgileX) and rehabilitation (Fourier). Rather than picking one robot winner, HongShan funded each layer of the stack — the same decomposition MiraclePlus backs at pre-seed prices, at growth scale.
Roughly five years before the institutional crowd, which only discovered the category around 2025. From 2020 it systematically backed Neuracle, NeuroXess, Zhiran Medical and SceneRay — implantable BCI, flexible high-bandwidth electrodes and neuromodulation — with partner Yunxia Yang leading Neuracle internally. An internally-led cluster signals a house thesis rather than opportunism, and the hold so far is unusually patient for venture pacing.
An acquired company belongs to the history of an investor’s backing, but it should not automatically be counted as an independent company or a current holding. Read the acquisition and investment disclosures separately; the acquisition does not establish whether the investor retained an interest afterward.